BlackRock-advised Funds > iShares Trust
iShares U.S. Pharmaceuticals ETF
$484.70M
Avg Monthly Net Assets
$699.49M
Total Assets
$16.01M
Total Liabilities
$683.48M
Net Assets
iShares U.S. Pharmaceuticals ETF is an Exchange-Traded Fund in iShares Trust
from BlackRock-advised Funds,
based in California,
United States of America.
The fund has one share class
and monthly net assets of $484.70M.
On August 26th, 2024 it reported 39 holdings, the largest
being ELI LILLY AND COMPANY (23.6%), JOHNSON & JOHNSON (22.7%) and PFIZER INC. (4.6%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| iShares U.S. Pharmaceuticals ETF | C000025771 | ARCX | IHE |
Holdings
From latest NPORT-P, filed August 26th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| AMNEAL PHARMACEUTICALS INC (AMNEAL PHARMACEUTICALS, INC.) | Long | Equity-common | US | $2M | 320K | 0.30 |
| AMPHASTAR PHARMACEUTICALS INC | Long | Equity-common | US | $4M | 107K | 0.63 |
| ANI PHARMACEUTICALS INC (ANI PHARMACEUTICALS, INC.) | Long | Equity-common | US | $3M | 43K | 0.40 |
| ARVINAS INC | Long | Equity-common | US | $5M | 192K | 0.75 |
| AXSOME THERAPEUTICS INC (AXSOME THERAPEUTICS, INC.) | Long | Equity-common | US | $9M | 109K | 1.29 |
| BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY (BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares) | Long | Short-term investment vehicle | US | $16M | 16M | 2.31 |
| BLACKROCK CASH FUNDS TREASURY (BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares) | Long | Short-term investment vehicle | US | $322K | 322K | 0.05 |
| BRISTOL MYERS SQUIBB CO (BRISTOL-MYERS SQUIBB COMPANY) | Long | Equity-common | US | $30M | 727K | 4.42 |
| CASSAVA SCIENCES INC (CASSAVA SCIENCES, INC.) | Long | Equity-common | US | $2M | 126K | 0.23 |
| CATALENT INC (CATALENT, INC.) | Long | Equity-common | US | $29M | 507K | 4.17 |
| COLLEGIUM PHARMACEUTICAL INC (Collegium Pharmaceutical, Inc.) | Long | Equity-common | US | $3M | 92K | 0.43 |
| CORCEPT THERAPEUTICS INC (CORCEPT THERAPEUTICS INCORPORATED) | Long | Equity-common | US | $8M | 257K | 1.22 |
| EDGEWISE THERAPEUTICS INC | Long | Equity-common | US | $4M | 196K | 0.52 |
| ELANCO ANIMAL HEALTH INC (ELANCO ANIMAL HEALTH INCORPORATED) | Long | Equity-common | US | $20M | 1M | 2.92 |
| ELI LILLY CO (ELI LILLY AND COMPANY) | Long | Equity-common | US | $161M | 178K | 23.55 |
| ENLIVEN THERAPEUTICS INC | Long | Equity-common | US | $2M | 69K | 0.24 |
| HARMONY BIOSCIENCES HOLDINGS INC (HARMONY BIOSCIENCES HOLDINGS, INC.) | Long | Equity-common | US | $3M | 89K | 0.39 |
| INNOVIVA INC (INNOVIVA, INC.) | Long | Equity-common | US | $3M | 154K | 0.37 |
| INTRA CELLULAR THERAPIES INC (Intra-Cellular Therapies Inc) | Long | Equity-common | US | $19M | 275K | 2.76 |
| JAZZ PHARMACEUTICALS PLC (JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $19M | 177K | 2.76 |
| JOHNSON JOHNSON (JOHNSON & JOHNSON) | Long | Equity-common | US | $155M | 1M | 22.68 |
| LIGAND PHARMACEUTICALS (LIGAND PHARMACEUTICALS INCORPORATED) | Long | Equity-common | US | $4M | 47K | 0.58 |
| MERCK CO INC (MERCK & CO., INC.) | Long | Equity-common | US | $29M | 237K | 4.29 |
| MIND MEDICINE MINDMED INC (Mind Medicine (MindMed) Inc) | Long | Equity-common | CA | $1M | 183K | 0.19 |
| NUVATION BIO INC | Long | Equity-common | US | $1M | 455K | 0.19 |
| ORGANON CO (ORGANON & CO.) | Long | Equity-common | US | $15M | 720K | 2.18 |
| PACIRA BIOSCIENCES INC (PACIRA BIOSCIENCES, INC.) | Long | Equity-common | US | $4M | 130K | 0.55 |
| PERRIGO CO PLC (PERRIGO COMPANY PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $10M | 382K | 1.43 |
| PFIZER INC (PFIZER INC.) | Long | Equity-common | US | $31M | 1M | 4.56 |
| PLIANT THERAPEUTICS INC | Long | Equity-common | US | $2M | 147K | 0.23 |
| PRESTIGE CONSUMER HEALTH (PRESTIGE CONSUMER HEALTHCARE INC.) | Long | Equity-common | US | $10M | 140K | 1.41 |
| REVANCE THERAPEUTICS INC (REVANCE THERAPEUTICS, INC.) | Long | Equity-common | US | $752K | 293K | 0.11 |
| ROYALTY PHARMA PLC | Long | Equity-common | GB | $29M | 1M | 4.19 |
| SUPERNUS PHARMACEUTICALS INC (SUPERNUS PHARMACEUTICALS, INC.) | Long | Equity-common | US | $4M | 154K | 0.60 |
| TARSUS PHARMACEUTICALS INC | Long | Equity-common | US | $2M | 85K | 0.34 |
| THERAVANCE BIOPHARMA INC (THERAVANCE BIOPHARMA, INC.) | Long | Equity-common | KY | $798K | 94K | 0.12 |
| VIATRIS INC (VIATRIS INC.) | Long | Equity-common | US | $31M | 3M | 4.51 |
| XAV HEALTH CARE SEP24 | Derivative-equity | US | $239.58 | – | 0.00 | |
| ZOETIS INC (ZOETIS INC.) | Long | Equity-common | US | $30M | 175K | 4.45 |
Address
iShares Trust
400 Howard Street
San Francisco
California
94105
United States of America
Websites
Directors
John E. Kerrigan
Richard L. Fagnani
Robert S. Kapito
Drew E. Lawton
Stephen Cohen
John E. Martinez
Madhav V. Rajan
Jane D. Carlin
Cecilia H. Herbert
Transfer Agents
Citibank, N.A.
Pricing Services
Refinitiv US Holdings Inc.
ICE Data Services, Inc.
Bloomberg L.P.
Custodians
Citibank, N.A.
SG Americas Securities, LLC
Shareholder Servicing Agents
N/A
Admins
Citi Fund Services Ohio, Inc.
Brokers
Barclays Capital Inc.
Morgan Stanley & Co. LLC
Jefferies LLC
J.P. Morgan Securities LLC
UBS Securities LLC
BNP Paribas Securities Corp.
Goldman Sachs & Co. LLC
Merrill Lynch, Pierce, Fenner & Smith Incorporated
CASTLE OAK SECURITIES, L.P.
Instinet, LLC